PharmaBoardroom

Novo Nordisk is one of the very few pharmaceutical multinationals that have a strong focus on one therapeutic area. Although the company has a…

Please can you give us a rundown of Shires activities in Mexico in the last four years, and the key achievements and milestones along the way? Shire…

Please can you give our readers a brief rundown of the major milestones and challenges that you have faced at Octapharma since becoming Managing…

From your perspective in healthcare consultancy at CEGEDIM, what do you think have been the most impactful changes in the Mexican pharmaceutical and…

As a promoter and “sales agent” for Bogotá and Colombia can please you take us through the country’s journey over the past decade and how this…

Could you provide us with an introduction to the company and an overview of operations from the company’s founding through to your position…

While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a…

You began your career at Pfizer, working your way up the organizational ladder, when suddenly you decided to come to China back in 2001, well before…

This interview was conducted with Christopher Stephens, managing partner of Orrick, Herrington & Sutcliffe's Asia offices with supporting…

Finnegan is a leader and expert on the topic of intellectual property and it entered Asia in the late 1980s with an office in Tokyo yet China only…

First, let me briefly introduce myself. I used to work in Fuxin, a small city in the industrially advanced province of Liaoning which is equivalent…

Hooker Cockram is a well established company with an, impressive and rich history. Could you give us some background on both your operations in…